Vas Narasimhan — SPARQNOW

At-a-Glance

Chief Executive Officer of Novartis since 2017.
Leads Novartis's focus on advanced therapy platforms, including cell therapy, gene therapy, RNA therapeutics, and radioligand therapy.
Served as Global Head of Drug Development and Chief Medical Officer at Novartis from 2016 to 2018.
Holds an M.D. from Harvard Medical School and a master's degree in public policy from the John F. Kennedy School of Government.
Earned a bachelor's degree in biological sciences from the University of Chicago.

Biography

Vasant "Vas" Narasimhan is an American physician and the chief executive officer of Novartis, a global pharmaceutical company. He assumed the CEO role in 2018, succeeding Joseph Jimenez. At Novartis, he focuses on reimagining medicine through innovative science and technology to address health issues, discover breakthrough treatments, and deliver them globally. He advocates for "unbossed leadership" to foster innovation and overcome challenges.